Infectex, Ltd.

Infectex announces partnership with Qurient for TB treatment

Russian biotech company Infectex, Ltd., recently announced that it has entered into license agreement with Qurient, Ltd., of Korea for the exclusive rights to develop and market Qurient’s Q203 treatment against Tuberculosis.

Read More →

Page 1 of 1 · Total posts: 1